Liu B A,Knowles S R,Mittmann N,et al. Reporting of fatal adverse drug reactions[J]. Can J Clin Pharmacol,2001,8:84.
[3]
Kelly W N. The quality of published adverse drug event reports:review[J]. Ann Pharmacother,2003,37:1774.
[4]
Kramer M S,Leventhal J M,Hutchinson T A,et al. An algorithm for the operational assessment of adverse drug reactions:I. Background,description,and instructions for use[J]. JAMA,1979,242:623.
[5]
Dangoumau J,Evreux J C,Jouglard J. Method for determination of undesirable effects of drugs[J]. Therapie,1978,33:373.
Naranjo C A,Busto U,Sellers E M,et al. A method for estimating the probability of adverse drug reactions[J]. Clin Pharmacol Ther,1981,30:239.
[8]
Kane-Gill S L,Kirisci L,Pathak D S. Are the Naranjo criteria reliable and valid for determination of adverse drug reactions in the intensive care unit?[J]. Ann Pharmacother,2005,39:1823.
[9]
Hoskins R E,Mannino S. Causality assessment of adverse drug reactions using decision support and informatics tools[J]. Pharmacoepidemiol Drug Saf,1992,1:235.
Emanueli A,Sacchetti G. An algorithm for the classification of untoward events in large scale clinical trials[J]. Agents Actions Suppl,1980,7:318.
[12]
Venulet J,Ciucci A,Berneker G C. Standardised assessment of drug-adverse reaction associations:rationale and experience[J]. Int J Clin Pharmacol Ther Toxicol,1980,18:381.
[13]
Jones J K. Adverse drug reactions in the community health setting:approaches to recognizing,counseling,and reporting[J]. Fam Community Health,1982,5:58.
[14]
Wiholm B E. The Swedish drug-event assessment methods: special workshop-regulatory[J]. Drug Inf J,1984,18:267.
Karch F E,Lasagna L. Toward the operational identification of adverse drug reactions[J]. Clin Pharmacol Ther,1977,21:247.
[18]
Naranjo C A,Busto U,Sellers E M,et al. A method for estimating the probability of adverse drug reactions[J]. Clin Pharmacol Ther,30(2):239.
[19]
Benichou C,Danan G,Flahault A. Causality assessment of adverse reactions to drugs:II.An original model for validation of drug causality assessment methods:case reports with positive rechallenge[J]. J Clin Epidemiol,1993,46:1331.
[20]
Hoskins R E,Mannino S. Causality assessment of adverse drug reactions using decision support and informatics tools[J]. Pharmacoepidemiol Drug Saf,1992,1:235.
[21]
Arimone Y,Begaud B,Miremont-Salame G,et al. A new method for assessing drug causation provided agreement with experts\' judgment[J]. J Clin Epidemiol,2006,59:308.
[22]
World Health Organization(WHO),Uppsala Monitoring Centre. The use of the WHO-UMC system for standardised case causality assessment. WHO.. http://www.who-umc.org/graphics/26649.pdf.
